Skip to content
Dose Brief
Menu
Head-to-head · Brief Score

CoreAge Rx vs Try Ageless

Two GLP-1 providers, one scoreboard. We put CoreAge Rx and Try Ageless head-to-head on the published Brief Score — the same six factors, scored the same way.

Higher Brief ScoreNo. 1 · Grade A

CoreAge Rx

Visit CoreAge Rx Full brief →
vs
No. 405 · Grade C

Try Ageless

Visit Try Ageless Full brief →

FDA warning letter, September 2025 — issued to Lovely Meds, Inc. dba Lovely Meds. Try Ageless's own medical-oversight page identifies Lovely Meds, Inc. as the company that operates tryageless.com. The letter concerns lovelymeds.com, does not name tryageless.com, and FDA has not closed it out. See the FDA's warning letter database.

The verdict

CoreAge Rx takes this head-to-head.

CoreAge Rx scores 94 to 58 on our six-factor Brief Score — CoreAge publishes different starting offers across its pages; the advertised annual rates require a full year paid upfront.

That doesn't make Try Ageless a bad call — it's best for readers who want a choice of injection or sublingual drops from a provider that will name the pharmacy and the prescriber — and who will read past the hero to the month-to-month column. Weigh the six factors below against your own priorities before you decide.

Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Brief Score.

Factor by factor

Both providers scored on the six published Brief Score factors. The higher score in each row is marked. See the methodology.

Price Stability
97
60
Supply Reliability
95
70
Transparency
90
48
Access Breadth
93
62
Clinical Oversight
92
62
Track Record
88
42
CoreAge RxBrief Score 94 · 58Try Ageless

Price, coverage & the tracker

CoreAge RxTry Ageless
Brief Score94/100 (A)58/100 (C)
Semaglutide

From $79/mo

Annual offer: 12 months paid upfront, from $948.

Main site: from $99/mo; confirm the selected offer.

Full price details

From $79/mo on the annual-plan landing offer, based on a 12-month plan paid in full ($948 at that starting rate); main product page separately advertises from $99/mo

$279/mo month-to-month, compounded injection — the "from $199" beside it is the 12-month rung, billed as $2,388 up front

Tirzepatide

From $129/mo

Annual offer: 12 months paid upfront, from $1,548.

Main site: from $149/mo; confirm the selected offer.

Full price details

From $129/mo on the annual-plan landing offer, based on a 12-month plan paid in full ($1,548 at that starting rate); main product page separately advertises from $149/mo

$349/mo month-to-month, compounded injection; sublingual drops $199/mo — the "from $249" and "from $159" on the same page are 12-month rungs ($2,988 and $1,908 up front)

CoverageUS only; restrictions by state, confirmed at intakeCoverage not published anywhere on the site
Brand-name accessNot confirmedNot confirmed
Oral / sublingualInjection onlyYes
On the trackerStableprice stableNewnew to the tracker, no prior reading

CoreAge Rx: The checked annual-plan offer starts at $79/$129 per month on annual prepay; the main product pages still show $99/$149. Confirm the selected offer.

Try Ageless: Month-to-month prices are $279 for semaglutide injection, $349 for tirzepatide injection and $199 for tirzepatide drops. The lower advertised $159/$199/$249 rates require twelve-month prepayment; a separate one-time semaglutide listing is $119–229 depending on dose.

Keep comparing

Pricing, states and access reflect each provider's public disclosures at last review; the Brief Score is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.